News
Contact Us
Support

Home
Our Philosophy
OVITEX
Investors

Press Releases
Events & Presentations

News Releases

News Releases

Year

Nov 13, 2019

TELA Bio Appoints Federica O’Brien to Board of Directors

Nov 13, 2019

TELA Bio Announces Closing of Initial Public Offering of Common Stock

Nov 07, 2019

TELA Bio Announces Pricing of Initial Public Offering of Common Stock

Jun 13, 2019

TELA Bio® to Participate in JMP Securities Life Sciences Conference

Jun 06, 2019

TELA Bio® Announces One-Year Data from BRAVO Study of OviTex® Reinforced BioScaffolds for Ventral Hernia Repair

Apr 25, 2019

TELA Bio® Appoints Kurt Azarbarzin Chairman of Board of Directors

Apr 18, 2019

TELA Bio® Announces 510(k) Clearance for Restella™ Reconstructive BioScaffolds for Reconstructive Surgery

Apr 08, 2019

TELA Bio® to Present at 18th Annual Needham Healthcare Conference

Mar 11, 2019

TELA Bio® Announces Multiple Presentations at American Hernia Society Annual Meeting in Las Vegas

Jan 24, 2019

TELA Bio Announces First Patient in Europe Treated with OviTex®

Pagination

Current page 1
Page 2
Next page
Last page

Print Page

RSS Feeds

Email Alerts

Contact IR

Privacy Policy
Legal
Contact Us

Linkedin
Facebook

©2019 TELA Bio, Inc. All Rights reserved.